chronic%20stable%20angina
CHRONIC STABLE ANGINA
Chronic stable angina is a clinical syndrome characterized by squeezing, heaviness or pressure discomfort in the chest, neck, jaw, shoulder, back, or arms which is usually precipitated by exertion and/or emotional stress and relieved by rest and/or Nitroglycerin.
It is caused by myocardial ischemia that is commonly associated with narrowing of the coronary arteries.
Angina is stable when it is not a new symptom and when there is no deterioration in frequency, duration or severity of episodes.

Prevention

Influenza Vaccination

  • Annual influenza vaccination is recommended for patients with ischemic heart disease (IHD) especially the elderly
    • Decreases exacerbation of underlying medical condition and risk for mortality in patients with chronic illnesses such as cardiovascular (CV) disease

Follow Up

  • Patients with stable ischemic heart disease (SIHD) should have regular follow-up every 4-6 months during the first year of therapy and 6-12 months after the first year if the patient is stable and reliable to know when symptoms or functional capacity becomes worse
  • Evaluation includes:
    • Assessment of symptoms and clinical function
    • Surveillance for complications such as arrhythmias and heart failure
    • Monitoring of cardiac risk factors
    • Assessment of the adequacy and compliance to lifestyle modifications and medical therapy
  • Reassessment of prognosis via stress test every 3-5 years for low-risk/asymptomatic patients after warranty of previous stress test
  • Periodic screening of comorbidities that are prevalent in patients with SIHD such as diabetes mellitus (DM), depression, and chronic renal disease
  • Resting electrocardiogram (ECG) at 1-year or longer intervals between studies in patients with stable symptoms can also be performed
    • Additional ECG is suggested if patient experiences arrhythmia, anginal symptoms, or if therapy has been modified
  • Exercise ECG or stress imaging is recommended if there are changes in frequency of symptoms or new symptoms occur
    • Repeat exercise ECG may be done after 2 years if stable
  • Assessment of left ventricular ejection fraction (LVEF) and segmental wall motion by echocardiography or radionuclide imaging is recommended in patients with new or worsening heart failure or evidence of intervening myocardial infarction (MI) by history or ECG
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
12 Aug 2019
Treatment with nebivolol yields more favourable changes in 24-hour, intradialytic and daytime systolic and diastolic blood pressure variability in patients with intradialytic hypertension, a study has found.
Stephen Padilla, 25 Jul 2019
Nonvitamin K antagonist oral anticoagulants (NOACs) appear to confer more clinical benefits to elderly patients with atrial fibrillation (AF) than vitamin K antagonist anticoagulants (VKAs), suggests a study, adding that this is primarily driven by the lower rates of major bleeding.
11 Aug 2019
Intraoperative methylprednisolone does not appear to significantly prevent the incidence of death, cardiac arrest and other injuries in neonates undergoing cardiac surgery with cardiopulmonary bypass, according to a recent study.
25 Jul 2019
Adding a third drug to achieve the target blood pressure (BP) seems to be more effective than increasing the dose of existing dual therapy without any increase in adverse events, suggest the results of a meta-analysis, adding that early use of triple therapy can help improve hypertension control.